查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631880

院內感染控制市場 - 全球行業規模、佔有率、趨勢、機會和預測，按產品、應用、技術、疾病、最終用戶、地區和競爭細分，2020-2030F

Hospital Acquired Infection Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Technology, By Disease, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年，全球院內感染控制市場估值為311.1 億美元，預計到2030 年，預測期內將實現令人印象深刻的成長，複合年成長率為4.21%。控制市場由幾個關鍵因素驅動。對預防醫院感染的迫切需求的認知不斷提高是主要驅動力，醫院感染嚴重影響病人安全和醫療費用。疾病預防控制中心和世界衛生組織等衛生當局的監管要求和指南增加了醫療機構中嚴格感染控制措施的採用。醫療技術的進步和創新感染控制產品的開發，如抗菌塗層和先進的滅菌設備，也推動了市場的發展。抗生素抗藥性細菌的日益流行，更加凸顯了對有效感染控制策略的關注。 COVID-19 大流行進一步凸顯了強力的感染預防方案的重要性，加速了對感染控制解決方案的投資。外科手術數量的增加和老年人口的增加（他們更容易受到感染）促進了市場的成長。總體而言，監管壓力、技術進步和意識的提高共同推動了全球院內感染控制市場的強勁擴張。

市場概況
預測期 2026-2030
2024 年市場規模 311.1億美元
2030 年市場規模 399.4億美元
2025-2030 年複合年成長率 4.21%
成長最快的細分市場 消毒器
最大的市場 北美洲

主要市場促進因素

院內感染發生率上升

嚴格的監管要求和指南

感染控制的技術進步

人口老化和脆弱性增加

醫院感染的經濟與健康負擔

主要市場挑戰

先進感染控制措施的成本高昂

感染控制協議的遵守情況不一致

主要市場趨勢

提高認知和教育

醫療保健支出不斷成長

細分市場洞察

產品洞察

最終使用者見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球院內感染控制市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（滅菌器、消毒器、內視鏡清洗機等）
    • 按應用（疾病檢測、抗藥性檢測）
    • 依技術（表現型方法、基因型方法）
    • 依疾病分類（院內獲得性肺炎、血流感染、手術部位感染、腸胃道感染、泌尿道感染等）
    • 按最終使用者（醫院、重症監護室、門診手術、診斷中心、療養院、婦產中心等）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖

第 6 章：北美院內感染控制市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 按疾病分類
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲醫院感染控制市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 按疾病分類
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區醫院感染控制市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 按疾病分類
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲醫院感染控制市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 按疾病分類
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲院內感染控制市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 按疾病分類
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Becton, Dickinson and Company
  • STERIS Plc
  • Advanced Sterilization Products Services Inc.
  • Getinge AB
  • Kimberly-Clark Corporation
  • Cantel Medical Corporation
  • BioMerieux SA
  • Belimed AG
  • 3M Company
  • Sterigenics International LLC

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 7617

Global Hospital Acquired Infection Control Market was valued at USD 31.11 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.21% through 2030. The Global Hospital Acquired Infection (HAI) Control Market is driven by several key factors. Rising awareness of the critical need to prevent HAIs, which significantly impact patient safety and healthcare costs, is a primary driver. Regulatory mandates and guidelines by health authorities like the CDC and WHO have increased the adoption of stringent infection control measures in healthcare facilities. Advances in medical technology and the development of innovative infection control products, such as antimicrobial coatings and advanced sterilization equipment, also propel the market. The growing prevalence of antibiotic-resistant bacteria has heightened the focus on effective infection control strategies. The COVID-19 pandemic further underscored the importance of robust infection prevention protocols, accelerating investments in infection control solutions. The increasing number of surgical procedures and the expanding elderly population, who are more susceptible to infections, contribute to the market's growth. Overall, a combination of regulatory pressures, technological advancements, and heightened awareness drives the robust expansion of the Global Hospital Acquired Infection Control Market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 31.11 Billion
Market Size 2030USD 39.94 Billion
CAGR 2025-20304.21%
Fastest Growing SegmentSterilizers
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Hospital Acquired Infections

Hospital Acquired Infections (HAIs), also known as nosocomial infections, are infections that patients acquire during their stay in healthcare facilities. The rising incidence of HAIs globally is a significant driver of the HAI control market. The study reported an overall incidence rate of nosocomial infections at 6.6 cases per 1,000 person-days of observation (95% CI: 5.1-8.7) and a prevalence of 8.88%. Over the course of the study, participants were monitored for a cumulative total of 7,984 person-days, with a median observation period of 10 days (IQR: 7-16 days). Factors contributing to this increase include the higher number of invasive procedures, the widespread use of indwelling medical devices like catheters and ventilators, and the prolonged hospital stays of patients with chronic diseases. According to the World Health Organization (WHO), hundreds of millions of patients are affected by HAIs each year, leading to a substantial burden on healthcare systems. This growing prevalence highlights the critical need for effective infection control measures to prevent the spread of these infections, thus driving the demand for HAI control products and services.

Stringent Regulatory Requirements and Guidelines

Regulatory bodies around the world, such as the Centers for Disease Control and Prevention (CDC) in the United States, the European Centre for Disease Prevention and Control (ECDC), and the WHO, have established stringent guidelines and requirements for infection control in healthcare settings. These regulations mandate healthcare facilities to adopt comprehensive infection control practices to ensure patient safety. Compliance with these guidelines often requires significant investment in infection control products and technologies, including sterilization equipment, disinfectants, and personal protective equipment (PPE). Failure to comply with these regulations can result in severe penalties and legal actions, further incentivizing healthcare providers to prioritize infection control. The enforcement of these stringent regulations is a major driver of the HAI control market.

Technological Advancements in Infection Control

The continuous advancements in medical technology play a crucial role in driving the HAI control market. Innovations in infection control include the development of advanced sterilization methods, antimicrobial coatings for medical devices and surfaces, and automated disinfection systems. For instance, ultraviolet (UV) light disinfection robots and hydrogen peroxide vapor systems have shown high efficacy in eliminating pathogens in healthcare environments. The integration of artificial intelligence (AI) and data analytics in infection control systems allows for real-time monitoring and early detection of infection outbreaks. These technological advancements enhance the effectiveness and efficiency of infection control measures, making them more appealing to healthcare providers and boosting market growth.

Aging Population and Increased Vulnerability

The aging global population is another significant driver of the HAI control market. By 2030, one in six people globally will be aged 60 or older, with the population in this age group rising from 1 billion in 2020 to 1.4 billion. By 2050, the global population of individuals aged 60 and above is projected to double to 2.1 billion. Furthermore, the number of people aged 80 and older is anticipated to triple during the same period, reaching 426 million.

This demographic shift, referred to as population aging, represents a growing concentration of older individuals within a population. While initially prevalent in high-income nations-such as Japan, where 30% of the population is already aged 60 or above-the most significant changes are now occurring in low- and middle-income countries. By 2050, these countries will account for two-thirds of the global population aged 60 and older, reflecting a profound transformation in global demographics. Elderly individuals are more susceptible to infections due to weakened immune systems and the higher likelihood of having chronic conditions that require frequent medical interventions. As the proportion of elderly individuals in the population increases, so does the number of hospital admissions and the need for invasive procedures, both of which elevate the risk of HAIs. This demographic trend necessitates enhanced infection control measures in healthcare settings to protect this vulnerable population. Consequently, the growing elderly population drives the demand for advanced infection control solutions, contributing to market expansion.

Economic and Health Burden of HAIs

The economic and health burden imposed by HAIs on healthcare systems is a significant driver of the HAI control market. The estimated costs of the Infection Prevention and Control (IPC) Program account for 2-3% of the hospital's annual budget. In the absence of the IPC Program, the World Health Organization (WHO) projects that the hospital would have recorded 570 healthcare-associated infections (HAIs), representing 15% of inpatients. Through the implementation of the IPC Program, an estimated 310 HAIs were prevented, resulting in a total cost savings of $1,103,577.99. HAIs result in extended hospital stays, increased medical costs, and additional treatments, which place a substantial financial strain on healthcare providers and payers. HAIs can lead to severe complications and higher mortality rates, highlighting the urgent need for effective infection control. Recognizing these challenges, healthcare providers are increasingly investing in infection control measures to reduce the incidence of HAIs and the associated economic and health burden. This focus on cost-effective infection prevention strategies drives the demand for HAI control products and services, propelling market growth.

Key Market Challenges

High Costs of Advanced Infection Control Measures

One of the significant challenges in the Global Hospital Acquired Infection (HAI) Control Market is the high cost associated with advanced infection control measures. Implementing state-of-the-art technologies and maintaining rigorous infection control protocols require substantial financial investments. This includes the cost of purchasing and maintaining sophisticated sterilization equipment, automated disinfection systems, and advanced diagnostic tools. For instance, ultraviolet (UV) disinfection robots and hydrogen peroxide vapor systems, while highly effective, represent a considerable financial burden for many healthcare facilities, especially those in low- and middle-income countries.

Ongoing expenses for consumables such as personal protective equipment (PPE), disinfectants, and antimicrobial coatings further strain the budgets of healthcare providers. These costs are exacerbated by the need for continuous training of healthcare staff to ensure they are proficient in using the latest infection control technologies and adhere to updated protocols. Smaller hospitals and clinics with limited financial resources may struggle to afford these investments, resulting in uneven adoption of best practices and technologies across different regions and healthcare facilities. This financial barrier hampers the overall effectiveness of infection control efforts globally and perpetuates disparities in healthcare quality and patient safety.

Inconsistent Compliance with Infection Control Protocols

Ensuring consistent compliance with infection control protocols across various healthcare settings is a critical challenge in the HAI control market. Despite the availability of comprehensive guidelines and best practices, adherence to these protocols can vary significantly among healthcare providers. Factors contributing to inconsistent compliance include lack of training, insufficient staffing, high workload, and varying levels of commitment to infection control practices.

In many healthcare facilities, particularly those in resource-limited settings, staff may not receive adequate training on the latest infection control measures. High patient volumes and limited personnel can lead to lapses in protocol adherence, such as improper hand hygiene, inadequate sterilization of medical instruments, and incorrect use of PPE. These lapses can result in the spread of HAIs, undermining efforts to control infections.

The culture within healthcare institutions plays a crucial role in adherence to infection control practices. Facilities that prioritize infection prevention and foster a culture of safety are more likely to achieve higher compliance rates. However, changing organizational culture is a complex and gradual process that requires leadership commitment, continuous education, and the implementation of effective monitoring and feedback mechanisms. Addressing these challenges is essential to improve compliance and enhance the overall effectiveness of infection control programs.

Key Market Trends

Increasing Awareness and Education

Raising awareness about the importance of infection control among healthcare professionals, patients, and the general public is a vital driver of the HAI control market. Educational programs and training sessions aimed at healthcare workers emphasize the implementation of best practices for infection prevention, such as proper hand hygiene, the use of PPE, and the correct sterilization of medical instruments. Public health campaigns and awareness initiatives also play a crucial role in informing patients about the risks of HAIs and the importance of following infection control protocols. This increased awareness and education lead to better adherence to infection control measures, reducing the incidence of HAIs and driving the demand for related products and services.

Growing Healthcare Expenditure

The global increase in healthcare expenditure significantly contributes to the growth of the HAI control market. Governments and private sector entities are investing heavily in improving healthcare infrastructure, including infection control measures. This investment is driven by the recognition that preventing HAIs not only improves patient outcomes but also reduces healthcare costs associated with prolonged hospital stays, additional treatments, and legal liabilities. The allocation of substantial budgets for healthcare facilities to upgrade their infection control practices ensures a steady demand for infection control products and technologies. The economic burden of HAIs on healthcare systems motivates further investment in preventive measures, fueling market growth.

Segmental Insights

Product Insights

Based on the product, Sterilizers are currently dominating the global Hospital Acquired Infection (HAI) Control Market. This dominance is driven by several factors that make sterilizers an indispensable tool in the fight against HAIs. Sterilizers are essential for ensuring the complete elimination of all forms of microbial life, including bacteria, viruses, fungi, and spores, from medical instruments and surfaces. This level of thoroughness is crucial in preventing the transmission of infections in healthcare settings. Unlike disinfectors, which reduce the number of viable microorganisms to a safe level, sterilizers achieve a level of microbial kill that is necessary for surgical instruments and other critical medical devices that come into direct contact with sterile body tissues or fluids.

The broad applicability of sterilizers is another key factor in their market dominance. They are used across various healthcare settings, including hospitals, clinics, and surgical centers, for sterilizing a wide range of instruments, from surgical tools to laboratory equipment. This versatility makes them a fundamental component of infection control protocols in numerous medical environments. The advent of advanced sterilization technologies, such as steam sterilization, ethylene oxide (EO) sterilization, and low-temperature hydrogen peroxide gas plasma, has expanded their applicability and effectiveness, further driving their adoption.

End User Insights

Based on the end user segment, Hospitals stand out as the primary setting dominating the landscape of infection control efforts. This dominance is driven by several factors that highlight the pivotal role hospitals play in mitigating the risk and spread of HAIs. Hospitals serve as the epicenter of healthcare delivery, catering to a diverse range of patients with varying medical needs. Due to the high volume of patients and the complexity of medical procedures performed within hospital walls, the risk of HAIs is inherently elevated. Consequently, hospitals have implemented stringent infection control protocols and invested in state-of-the-art technologies to minimize this risk and uphold patient safety standards.

Intensive Care Units (ICUs) within hospitals play a particularly crucial role in infection control due to the vulnerable nature of patients receiving critical care. Patients in ICUs often have compromised immune systems, making them more susceptible to infections. As a result, ICUs prioritize infection prevention measures, such as strict adherence to hand hygiene protocols, rigorous environmental cleaning, and the use of specialized equipment for sterilization and disinfection.

Regional Insights

In North America, countries like the United States and Canada have stringent regulations and guidelines in place to ensure compliance with infection control protocols in healthcare settings. Organizations such as the Centers for Disease Control and Prevention (CDC) in the U.S. and the Public Health Agency of Canada provide comprehensive guidance on infection prevention and control practices, shaping the standard of care across the region. North America is home to some of the world's leading manufacturers of infection control products and technologies. Companies based in this region continually innovate and develop cutting-edge solutions to address the evolving challenges posed by HAIs. These advancements range from novel disinfection methods to sophisticated surveillance systems that enable real-time monitoring of infection rates within healthcare facilities.

North America has a strong culture of collaboration and knowledge sharing among healthcare professionals, academic institutions, and industry stakeholders. This collaborative approach fosters innovation and drives continuous improvement in infection control strategies, positioning the region at the forefront of the global fight against HAIs.

Key Market Players

  • Becton, Dickinson and Company
  • STERIS Plc
  • Advanced Sterilization Products Services Inc.
  • Getinge AB
  • Kimberly-Clark Corporation
  • Cantel Medical Corporation
  • BioMerieux SA
  • Belimed AG
  • 3M Company
  • Sterigenics International LLC

Report Scope:

In this report, the Global Hospital Acquired Infection Control Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hospital Acquired Infection Control Market, By Product:

  • Sterilizers
  • Disinfectors
  • Endoscope Reprocessors
  • Others

Hospital Acquired Infection Control Market, By Application:

  • Disease Testing
  • Drug-Resistance Testing

Hospital Acquired Infection Control Market, By Technology:

  • Phenotypic Methods
  • Genotypic Methods

Hospital Acquired Infection Control Market, By Disease:

  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • UTI
  • Others

Hospital Acquired Infection Control Market, By End User:

  • Hospitals
  • ICUs
  • Ambulatory Surgical
  • Diagnostic Centers
  • Nursing Homes
  • Maternity Centers
  • Others

Hospital Acquired Infection Control Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hospital Acquired Infection Control Market.

Available Customizations:

Global Hospital Acquired Infection Control market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hospital Acquired Infection Control Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Others)
    • 5.2.2. By Application (Disease Testing, Drug-Resistance Testing)
    • 5.2.3. By Technology (Phenotypic Methods, Genotypic Methods)
    • 5.2.4. By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others)
    • 5.2.5. By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2023)
  • 5.3. Market Map

6. North America Hospital Acquired Infection Control Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Technology
    • 6.2.4. By Disease
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hospital Acquired Infection Control Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By Disease
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Hospital Acquired Infection Control Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By Disease
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Hospital Acquired Infection Control Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By Disease
        • 6.3.3.2.5. By End User

7. Europe Hospital Acquired Infection Control Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Technology
    • 7.2.4. By Disease
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hospital Acquired Infection Control Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Disease
        • 7.3.1.2.5. By End User
    • 7.3.2. United Kingdom Hospital Acquired Infection Control Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Disease
        • 7.3.2.2.5. By End User
    • 7.3.3. Italy Hospital Acquired Infection Control Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Disease
        • 7.3.3.2.5. By End User
    • 7.3.4. France Hospital Acquired Infection Control Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Disease
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Hospital Acquired Infection Control Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Disease
        • 7.3.5.2.5. By End User

8. Asia-Pacific Hospital Acquired Infection Control Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Technology
    • 8.2.4. By Disease
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Hospital Acquired Infection Control Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Disease
        • 8.3.1.2.5. By End User
    • 8.3.2. India Hospital Acquired Infection Control Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Disease
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Hospital Acquired Infection Control Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Disease
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Hospital Acquired Infection Control Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Disease
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Hospital Acquired Infection Control Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Disease
        • 8.3.5.2.5. By End User

9. South America Hospital Acquired Infection Control Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Technology
    • 9.2.4. By Disease
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Hospital Acquired Infection Control Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Disease
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Hospital Acquired Infection Control Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Disease
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Hospital Acquired Infection Control Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Disease
        • 9.3.3.2.5. By End User

10. Middle East and Africa Hospital Acquired Infection Control Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Technology
    • 10.2.4. By Disease
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Hospital Acquired Infection Control Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Disease
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Hospital Acquired Infection Control Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Disease
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Hospital Acquired Infection Control Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Disease
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Becton, Dickinson and Company
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. STERIS Plc
  • 14.3. Advanced Sterilization Products Services Inc.
  • 14.4. Getinge AB
  • 14.5. Kimberly-Clark Corporation
  • 14.6. Cantel Medical Corporation
  • 14.7. BioMerieux SA
  • 14.8. Belimed AG
  • 14.9. 3M Company
  • 14.10. Sterigenics International LLC

15. Strategic Recommendations

16. About Us & Disclaimer